Effects of chronic fenfluramine administration on hypothalamic neuropeptide mRNA expression

Brain Research
SuJean ChoiJohn D Fernstrom

Abstract

Appetite suppressants lose efficacy when given chronically; the mechanisms are unknown. We gave male rats once-daily dl-fenfluramine (dl-FEN, 5 mg/kg, i.p.) injections for 15 days and measured mRNA expression of corticotropin releasing factor (CRF), neuropeptide Y (NPY) and proopiomelanocortin (POMC) in hypothalamic neurons on days 1, 2 and 15. dl-FEN decreased food intake on days 1-2 but not on day 15. The drug increased CRF mRNA and decreased NPY mRNA on days 1-2; on day 15, NPY mRNA was normal, but CRF mRNA remained elevated. No changes occurred in POMC mRNA. Thus, only the NPY mRNA response to dl-FEN correlated with changes in food intake over time in a manner consistent with the known effects of NPY on food intake.

References

Mar 1, 1975·The Journal of Pharmacy and Pharmacology·J E BlundellR Tozer
Jan 1, 1987·Pharmacology & Therapeutics·M F Sugrue
Jan 1, 1986·Progress in Neurobiology·N E Rowland, J Carlton
Nov 1, 1995·Obesity Research·S Garattini
Jul 27, 2002·Science·Lora K HeislerJoel K Elmquist

❮ Previous
Next ❯

Citations

Jun 23, 2011·Reviews in Endocrine & Metabolic Disorders·Stephanie Sisley, Darleen Sandoval
Aug 4, 2012·Nature Reviews. Drug Discovery·Marcelo O Dietrich, Tamas L Horvath
Dec 25, 2013·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Jorge J Pérez MaceiraManuel Aldegunde
Nov 26, 2008·The Journal of Physiology·Alastair S Garfield, Lora K Heisler
Feb 3, 2016·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Jorge J Pérez-MaceiraManuel Aldegunde
Sep 15, 2010·Pharmacology, Biochemistry, and Behavior·Daniel D LamLora K Heisler
Oct 24, 2007·Pharmacology & Therapeutics·John D Fernstrom, Sujean Choi
Oct 1, 2015·Metabolic Brain Disease·Magdalena DudekMarcin Kołaczkowski
Jun 12, 2013·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·María J ManceboManuel Aldegunde
Sep 15, 2014·Behavioural Brain Research·Jörg-Peter Voigt, Heidrun Fink
Aug 10, 2016·The Journal of Comparative Neurology·Gábor WittmannRonald M Lechan
Apr 7, 2009·Regulatory Peptides·Jan A MennigenVance L Trudeau
May 1, 2019·Journal of the Royal Army Medical Corps·Maxwell Mehlman
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Lori Asarian, Thomas Bächler
Aug 6, 2015·Journal of Veterinary Science·Hye Kyung BaekSun Shin Yi
Sep 21, 2018·Frontiers in Neuroscience·Ana P S DornellasEliane B Ribeiro
Apr 26, 2021·Pharmacology & Therapeutics·Reem OdiEmilio Perucca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.